UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

NCT05775666 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: UCLM802 Cell Injection

Sponsor

Peking University

Collaborators

[object Object]